Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Sarepta To Contact Him Directly To Discuss Their ...

Vinay Prasad's interim replacement has concerns about same drug that drove him out. NIH director says employee critics ...

Dealmaker-In-Chief” Donald Trump has been “positively monomaniacal” about trade lately, marvels Freddy Gray at The Spectator.

As Wall Street embarks on the first full week of August, the earnings wave continues with another stacked week of reports ...

The U.S. Food and Drug Administration (FDA) has recommended lifting the voluntary clinical hold on Elevidys for ambulatory patients with Duchenne Muscular Dystrophy (DMD), following a thorough ...